Video

Nanette B. Silverberg, MD: Diversifying Dermatology Studies

Author(s):

Dr. Silverberg speaks of the desire for more inclusive studies and educational resources on skin of color by patients and physicians alike.

In a recent entry of the This Year in Medicine series, prominent dermatologists spoke of racial disparities in the field of dermatology.

Of the myriad of reasons for these disparities, education on skin of color is a primary factor. Additionally, the education of skin of color is often influenced by location, exposure, and location.

In an interview with HCPLive, Nanette B. Silverberg, MD, Chief of Pediatric Dermatology for Mount Sinai Health System and Member of Society for Pediatric Dermatology, spoke of the lack of exposure that some dermatologists experience regarding skin of color.

Silverberg noted that while physicians in bigger cities across the US might treat a more diverse patient population, under-representation in training can be seen in various parts of the country, in addition to a lack of resources and educational tools on darker skin types.

Because of this, many physicians and dermatologists across the US have lobbied for the inclusion of darker skin types in current studies.

“It's wonderful that there's really so much interest in it now, but there have been so many physicians who are really truly dedicated to the topic in the past few decades, that have really helped bring it to the forefront,” Silverberg said. “But it's so important in education, because our population is becoming progressively more diverse, and also because disparity interacts with skin of color, particularly in the United States.”

To hear more of the changes regarding education of skin of color, watch the video above.

Related Videos
Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD
Discussing 140-Week Data on Upadacitinib for Atopic Dermatitis, with Raj Chovatiya, MD, PhD
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Linda Stein Gold, MD: Discussing New Phase 3b Data on Lebrikizumab for Atopic Dermatitis
New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
© 2024 MJH Life Sciences

All rights reserved.